F. Fenner, D. Henderson, I. Arita, Z. Jezek, and I. Ladnyi, Smallpox and its eradication, Geneva: World Health Organization, 1988.

D. Henderson, The Looming Threat of Bioterrorism, Science, vol.283, issue.5406, pp.1279-82, 1999.
DOI : 10.1126/science.283.5406.1279

M. Bray and M. Wright, Progressive Vaccinia, Clinical Infectious Diseases, vol.36, issue.6, pp.766-74, 2003.
DOI : 10.1086/374244

R. Chen and J. Lane, Myocarditis: the unexpected return of smallpox vaccine adverse events, The Lancet, vol.362, issue.9393, pp.1345-1351, 2003.
DOI : 10.1016/S0140-6736(03)14674-0

V. Fulginiti, A. Papier, J. Lane, J. Neff, and D. Henderson, Smallpox Vaccination: A Review, Part II. Adverse Events, Clinical Infectious Diseases, vol.37, issue.2, pp.251-71, 2003.
DOI : 10.1086/375825

J. Lane, F. Ruben, J. Neff, and J. Millar, Complications of smallpox vaccination, N Engl J Med, vol.969, issue.281, pp.1201-1209, 1968.

M. Bray, Pathogenesis and potential antiviral therapy of complications of smallpox vaccination, Antiviral Research, vol.58, issue.2, 2003.
DOI : 10.1016/S0166-3542(03)00008-1

J. Goldstein, J. Neff, J. Lane, and J. Koplan, Smallpox vaccination reactions, prophylaxis, and therapy of complications, Pediatrics, vol.55, pp.342-349, 1975.

R. Redfield, D. Wright, W. James, T. Jones, C. Brown et al., Disseminated Vaccinia in a Military Recruit with Human Immunodeficiency Virus (HIV) Disease, New England Journal of Medicine, vol.316, issue.11, pp.673-679, 1987.
DOI : 10.1056/NEJM198703123161106

C. Kempe, Studies smallpox and complications of smallpox vaccination, Pediatrics, vol.26, pp.176-89, 1960.

S. Vora, I. Damon, and V. Fulginiti, Severe Eczema Vaccinatum in a Household Contact of a Smallpox Vaccinee, Clinical Infectious Diseases, vol.46, issue.10, pp.1555-61, 2008.
DOI : 10.1086/587668

R. Greenberg and J. Kennedy, ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine, Expert Opinion on Investigational Drugs, vol.55, issue.4, pp.555-64, 2008.
DOI : 10.1086/511828

L. Handley, R. Buller, S. Frey, C. Bellone, and S. Parker, The new ACAM2000??? vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks, Expert Review of Vaccines, vol.8, issue.7, pp.841-50, 2009.
DOI : 10.1586/erv.09.55

A. Nalca and E. Zumbrun, ACAM2000™: The new smallpox vaccine for United States Strategic National Stockpile, Drug Design, Development and Therapy, vol.4, pp.71-80, 2010.
DOI : 10.2147/DDDT.S3687

S. Frey, F. Newman, and J. Kennedy, Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax?? in healthy vaccinia-naive adults, Vaccine, vol.27, issue.10, pp.1637-1681, 2009.
DOI : 10.1016/j.vaccine.2008.11.079

K. Marriott, C. Parkinson, S. Morefield, R. Davenport, R. Nichols et al., Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge, Vaccine, vol.26, issue.4, pp.581-589, 2008.
DOI : 10.1016/j.vaccine.2007.10.063

T. Beachkofsky, S. Carrizales, J. Bidinger, D. Hrncir, D. Whittemore et al., Adverse Events Following Smallpox Vaccination With ACAM2000 in a Military Population, Archives of Dermatology, vol.146, issue.6, pp.656-61, 2010.
DOI : 10.1001/archdermatol.2010.46

A. Artenstein, C. Johnson, and T. Marbury, A novel, cell culture-derived smallpox vaccine in vaccinia-na??ve adults, Vaccine, vol.23, issue.25, pp.3301-3310, 2005.
DOI : 10.1016/j.vaccine.2005.01.079

M. Slifka, The Future of smallpox vaccination: is MVA the key?, Med Immunol, vol.4, issue.2, 2005.

J. Kenner, F. Cameron, C. Empig, D. Jobes, and M. Gurwith, LC16m8: An attenuated smallpox vaccine, Vaccine, vol.24, issue.47-48, pp.7009-7031, 2006.
DOI : 10.1016/j.vaccine.2006.03.087

S. Morikawa, T. Sakiyama, and H. Hasegawa, An Attenuated LC16m8 Smallpox Vaccine: Analysis of Full-Genome Sequence and Induction of Immune Protection, Journal of Virology, vol.79, issue.18, pp.11873-91, 2005.
DOI : 10.1128/JVI.79.18.11873-11891.2005

M. Saijo, Y. Ami, and Y. Suzaki, LC16m8, a Highly Attenuated Vaccinia Virus Vaccine Lacking Expression of the Membrane Protein B5R, Protects Monkeys from Monkeypox, Journal of Virology, vol.80, issue.11, pp.5179-88, 2006.
DOI : 10.1128/JVI.02642-05

C. Empig, J. Kenner, and M. Perret-gentil, Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge, Vaccine, vol.24, issue.17, pp.3686-94, 2006.
DOI : 10.1016/j.vaccine.2005.03.029

T. Saito, T. Fujii, and Y. Kanatani, Clinical and Immunological Response to Attenuated Tissue-Cultured Smallpox Vaccine LC16m8, JAMA, vol.301, issue.10, pp.1025-1058, 2009.
DOI : 10.1001/jama.2009.289

C. Meseda, A. Mayer, and A. Kumar, Comparative Evaluation of the Immune Responses and Protection Engendered by LC16m8 and Dryvax Smallpox Vaccines in a Mouse Model, Clinical and Vaccine Immunology, vol.16, issue.9, 2009.
DOI : 10.1128/CVI.00040-09

G. Zaucha, P. Jahrling, T. Geisbert, J. Swearengen, and L. Hensley, The Pathology of Experimental Aerosolized Monkeypox Virus Infection in Cynomolgus Monkeys (Macaca fascicularis), Laboratory Investigation, vol.47, issue.12, pp.1581-600, 2001.
DOI : 10.1084/jem.185.6.1131

Y. Edghill-smith, H. Golding, and J. Manischewitz, Smallpox vaccine???induced antibodies are necessary and sufficient for protection against monkeypox virus, Nature Medicine, vol.23, issue.7, pp.740-747, 2005.
DOI : 10.1016/S0042-6822(02)00038-7

S. Gordon, A. Weissman, and V. Cecchinato, Preexisting Infection with Human T-Cell Lymphotropic Virus Type 2 neither Exacerbates nor Attenuates Simian Immunodeficiency Virus SIVmac251 Infection in Macaques, Journal of Virology, vol.84, issue.6, pp.3043-58, 2010.
DOI : 10.1128/JVI.01655-09

URL : https://hal.archives-ouvertes.fr/pasteur-00589395

J. Schmitz, M. Simon, and M. Kuroda, A Nonhuman Primate Model for the Selective Elimination of CD8+ Lymphocytes Using a Mouse-Human Chimeric Monoclonal Antibody, The American Journal of Pathology, vol.154, issue.6, pp.1923-1955, 1999.
DOI : 10.1016/S0002-9440(10)65450-8

J. Engram, B. Cervasi, and J. Borghans, Lineage-specific T-cell reconstitution following in vivo CD4+ and CD8+ lymphocyte depletion in nonhuman primates, Blood, vol.116, issue.5, pp.748-58, 2010.
DOI : 10.1182/blood-2010-01-263814

Y. Edghill-smith, D. Venzon, and T. Karpova, Modeling a Safer Smallpox Vaccination Regimen, for Human Immunodeficiency Virus Type 1???Infected Patients, in Immunocompromised Macaques, The Journal of Infectious Diseases, vol.188, issue.8, pp.1181-91, 2003.
DOI : 10.1086/378518

L. Rotz, D. Dotson, I. Damon, and J. Becher, Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, vol.001, issue.50 10, pp.1-25, 2001.

M. Vaccari, J. Mattapallil, and K. Song, Reduced Protection from Simian Immunodeficiency Virus SIVmac251 Infection Afforded by Memory CD8+ T Cells Induced by Vaccination during CD4+ T-Cell Deficiency, Journal of Virology, vol.82, issue.19, pp.9629-9667, 2008.
DOI : 10.1128/JVI.00893-08

K. Karem, M. Reynolds, and C. Hughes, Monkeypox-Induced Immunity and Failure of Childhood Smallpox Vaccination To Provide Complete Protection, Clinical and Vaccine Immunology, vol.14, issue.10, pp.1318-1345, 2007.
DOI : 10.1128/CVI.00148-07

T. Aragon, S. Ulrich, S. Fernyak, and G. Rutherford, Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, pp.1963-196826, 2003.

M. Kidokoro, M. Tashiro, and H. Shida, Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8, Proceedings of the National Academy of Sciences, vol.102, issue.11, pp.4152-4159, 2005.
DOI : 10.1073/pnas.0406671102

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC554788

E. Freyschmidt, C. Mathias, and N. Diaz, Skin Inflammation Arising from Cutaneous Regulatory T Cell Deficiency Leads to Impaired Viral Immune Responses, The Journal of Immunology, vol.185, issue.2, pp.1295-302, 2010.
DOI : 10.4049/jimmunol.0903144

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873154

Y. Kawakami, Y. Tomimori, and K. Yumoto, Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum, The Journal of Experimental Medicine, vol.131, issue.6, pp.1219-1244, 2009.
DOI : 10.4049/jimmunol.176.12.7736

J. Jensen, T. Sand, A. Jorgensen, and K. Thestrup-pedersen, Modulation of Natural Killer Cell Activity in Patients with Atopic Dermatitis, Journal of Investigative Dermatology, vol.82, issue.1, pp.30-34, 1984.
DOI : 10.1111/1523-1747.ep12259055

R. Lever, M. Lesko, R. Mackie, and D. Parrott, Natural-killer-cell activity in atopic dermatitis, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.108, issue.5, pp.483-90, 1984.
DOI : 10.1007/BF00403731

J. Verhagen, M. Akdis, and C. Traidl-hoffmann, Absence of T-regulatory cell expression and function in atopic dermatitis skin, Journal of Allergy and Clinical Immunology, vol.117, issue.1, pp.176-83, 2006.
DOI : 10.1016/j.jaci.2005.10.040

K. Orihara, M. Narita, and T. Tobe, Circulating Foxp3+CD4+ cell numbers in atopic patients and healthy control subjects, Journal of Allergy and Clinical Immunology, vol.120, issue.4, pp.960-962, 2007.
DOI : 10.1016/j.jaci.2007.05.036

S. Torreilles, R. Luong, S. Felt, and D. Mcclure, Tacrolimus ointment: a novel and effective topical treatment of localized atopic dermatitis in a rhesus macaque (Macaca mulatta), J Am Assoc Lab Anim Sci, vol.48, pp.307-318, 2009.